Abstract
Increasing evidence points to the role of oxidized phospholipids as modulators of inflammatory processes. These modified phospholipids are derived from lipoproteins or cellular membranes and accumulate at sites of inflammation such as atherosclerotic lesions. It has been shown that oxidized phospholipids influence a variety of cellular functions such as chemokine production and expression of adhesion molecules. Furthermore, recent reports indicate that oxidized phospholipids act as ligands for pattern-recognition receptors which detect conserved pathogen-associated molecular patterns during innate immune defense. Thus, the diversity of individual phospholipid oxidation products reflects the many aspects of the inflammatory process they influence. In this review, we focus on structural features used to classify different oxidized phospholipids and how they relate to specific biological responses. As the chemical identification of oxidized phospholipid products proceeds, distinctive structural motifs emerge that can help us to understand the mechanism of action of these unique compounds and how to intervene for therapeutic purposes.
Keywords: oxidized phospholipids, inflammation, molecular structure, Innate Immunity
Current Pharmaceutical Design
Title: Regulation of Inflammatory Responses by Oxidized Phospholipids: Structure-Function Relationships
Volume: 10 Issue: 8
Author(s): A. Furnkranz and N. Leitinger
Affiliation:
Keywords: oxidized phospholipids, inflammation, molecular structure, Innate Immunity
Abstract: Increasing evidence points to the role of oxidized phospholipids as modulators of inflammatory processes. These modified phospholipids are derived from lipoproteins or cellular membranes and accumulate at sites of inflammation such as atherosclerotic lesions. It has been shown that oxidized phospholipids influence a variety of cellular functions such as chemokine production and expression of adhesion molecules. Furthermore, recent reports indicate that oxidized phospholipids act as ligands for pattern-recognition receptors which detect conserved pathogen-associated molecular patterns during innate immune defense. Thus, the diversity of individual phospholipid oxidation products reflects the many aspects of the inflammatory process they influence. In this review, we focus on structural features used to classify different oxidized phospholipids and how they relate to specific biological responses. As the chemical identification of oxidized phospholipid products proceeds, distinctive structural motifs emerge that can help us to understand the mechanism of action of these unique compounds and how to intervene for therapeutic purposes.
Export Options
About this article
Cite this article as:
Furnkranz A. and Leitinger N., Regulation of Inflammatory Responses by Oxidized Phospholipids: Structure-Function Relationships, Current Pharmaceutical Design 2004; 10 (8) . https://dx.doi.org/10.2174/1381612043452929
DOI https://dx.doi.org/10.2174/1381612043452929 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Induced Pluripotent Stem Cells as a Model for Therapy Personalization of Pediatric Patients: Disease Modeling and Drug Adverse Effects Prevention
Current Medicinal Chemistry Gastrin-Releasing Peptide Receptor as a Molecular Target for Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Interleukin-21 in Immune-Mediated Pathologies
Current Drug Targets Gluten-dependent Intestinal Autoimmune Response
Current Pharmaceutical Design Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances
Current Drug Targets RNA Interference and Potential Applications
Current Topics in Medicinal Chemistry Sirtuins: Multifaceted Drug Targets
Current Molecular Medicine Polymers and Drug Delivery Systems
Current Drug Delivery Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology Prioritizing Disease Genes by Using Search Engine Algorithm
Current Bioinformatics Sorghum (Sorghum bicolor) Extract Affects Plasma Lipid Metabolism and Hepatic Macrophage Infiltration in Diabetic Rats
Current Nutrition & Food Science CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Engineering of Therapeutic Proteins Production in Escherichia coli
Current Pharmaceutical Biotechnology Towards Human on a Chip: Recent Progress and Future Perspective
Micro and Nanosystems Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness
Current Pharmaceutical Design (Iso)Flav(an)ones, Chalcones, Catechins, and Theaflavins as Anticarcinogens: Mechanisms, Anti-Multidrug Resistance and QSAR Studies
Current Medicinal Chemistry Editorial: Dissecting the Role of Mitochondria in the Pathophysiology of Type-2 Diabetes and Obesity: Novel Concepts and Challenges
Current Diabetes Reviews Polyethylene Glycol Acts as a Mechanistic Stabilizer of L-asparaginase: A Computational Probing
Medicinal Chemistry Editorial [Hot Topic: Telomeres and Telomerase in Diseases, Aging, and Carcinogenesis (Executive Editor: K. Lenhard Rudolph)]
Current Molecular Medicine Meet Our Editorial Board Member
Combinatorial Chemistry & High Throughput Screening